The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
The antibiotic resistance crisis, with a focus on the United States
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phylogenetic identification and in situ detection of individual microbial cells without cultivation
Amann, R., Ludwig, W., & SCHLEIFER, K. H. (1995) · Microbiological Reviews · doi:10.1128/mmbr.59.1.143-169.1995 · Cited by 9,093
Bacteriocins—A viable alternative to antibiotics?
Cotter, P. D., Ross, R. P., & Hill, C. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro2937 · Cited by 1,793
Extraction, Isolation And Characterization Of Bioactive Compounds From Plants’ Extracts
Sasidharan, S., Chen, Y., Saravanan, D., Sundram, K., & Latha, L. (2010) · African Journal of Traditional, Complementary and Alternative Medicines · doi:10.4314/ajtcam.v8i1.60483 · Cited by 1,456
Ikeda, H., Ishikawa, J., Hanamoto, A., Shinose, M., Kikuchi, H., Shiba, T., Sakaki, Y., Hattori, M., & Ōmura, S. (2003) · Nature Biotechnology · doi:10.1038/nbt820 · Cited by 1,241
TREATMENT OF STAPHYLOCOCCAL INFECTIONS WITH PENICILLIN BY INTERMITTENT STERILISATION
Bigger, J. (1944) · The Lancet · doi:10.1016/s0140-6736(00)74210-3 · Cited by 1,178
Spoering, A. L., & Lewis, K. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.23.6746-6751.2001 · Cited by 902
Advances in the development of new tuberculosis drugs and treatment regimens
Zumla, A., Nahid, P., & Cole, S. T. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4001 · Cited by 893
Strategies for culture of ‘unculturable’ bacteria: Culturing the unculturable
Vartoukian, S. R., Palmer, R. M., & Wade, W. G. (2010) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2010.02000.x · Cited by 718
Natural Products as Leads to Potential Drugs: An Old Process or the New Hope for Drug Discovery?
Newman, D. J. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm0704090 · Cited by 716
Activated ClpP kills persisters and eradicates a chronic biofilm infection
Conlon, B. P., Nakayasu, E. S., Fleck, L. E., LaFleur, M. D., Isabella, V. M., Coleman, K., Leonard, S. N., Smith, R. D., Adkins, J. N., & Lewis, K. (2013) · Nature · doi:10.1038/nature12790 · Cited by 672
Quinolones: from antibiotics to autoinducers
Heeb, S., Fletcher, M. P., Chhabra, S. R., Diggle, S. P., Williams, P., & Cámara, M. (2011) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2010.00247.x · Cited by 595
Status of the Microbial Census
Schloss, P. D., & Handelsman, J. (2004) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.68.4.686-691.2004 · Cited by 573
Metagenomics and industrial applications
Lorenz, P., & Eck, J. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1161 · Cited by 555
Udwary, D. W., Zeigler, L., Asolkar, R. N., Singan, V., Lapidus, A., Fenical, W., Jensen, P. R., & Moore, B. S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700962104 · Cited by 536
Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy
Ejim, L., Farha, M. A., Falconer, S. B., Wildenhain, J., Coombes, B. K., Tyers, M., Brown, E. D., & Wright, G. D. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.559 · Cited by 525
Antimicrobial peptides stage a comeback
Fox, J. L. (2013) · Nature Biotechnology · doi:10.1038/nbt.2572 · Cited by 524
Lederberg, J. (2000) · Science · doi:10.1126/science.288.5464.287 · Cited by 521
Applying insights from biofilm biology to drug development — can a new approach be developed?
Bjarnsholt, T., Ciofu, O., Molin, S., Givskov, M., & Høiby, N. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4000 · Cited by 516
Dysregulation of bacterial proteolytic machinery by a new class of antibiotics
Brötz-Oesterhelt, H., Beyer, D., Kroll, H.-P., Endermann, R., Ladel, C., Schroeder, W., Hinzen, B., Raddatz, S., Paulsen, H., Henninger, K., et al. (2005) · Nature Medicine · doi:10.1038/nm1306 · Cited by 505
Renaissance in antibacterial discovery from actinomycetes
BALTZ, R. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.04.008 · Cited by 498
Antibiotics in the clinical pipeline in 2013
Butler, M. S., Blaskovich, M. A., & Cooper, M. A. (2013) · The Journal of Antibiotics · doi:10.1038/ja.2013.86 · Cited by 433
Discovery of a new peptide natural product by Streptomyces coelicolor genome mining
Lautru, S., Deeth, R. J., Bailey, L. M., & Challis, G. L. (2005) · Nature Chemical Biology · doi:10.1038/nchembio731 · Cited by 362
Antibiotic resistance: The last resort
McKenna, M. (2013) · Nature · doi:10.1038/499394a · Cited by 360
The importance of new companies for drug discovery: origins of a decade of new drugs
Kneller, R. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3251 · Cited by 344
Natural products — The future scaffolds for novel antibiotics?
Butler, M. S., & Buss, A. D. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.10.012 · Cited by 337
Strategies for the Discovery of New Natural Products by Genome Mining
Zerikly, M., & Challis, G. L. (2009) · ChemBioChem · doi:10.1002/cbic.200800389 · Cited by 321
Global diversity and distribution of macrofungi
Mueller, G. M., Schmit, J. P., Leacock, P. R., Buyck, B., Cifuentes, J., Desjardin, D. E., Halling, R. E., Hjortstam, K., Iturriaga, T., Larsson, K.-H., et al. (2007) · Biodiversity and Conservation · doi:10.1007/s10531-006-9108-8 · Cited by 308
Antibiotic Resistance in Bacteria and Its Future for Novel Antibiotic Development
YONEYAMA, H., & KATSUMATA, R. (2006) · Bioscience, Biotechnology, and Biochemistry · doi:10.1271/bbb.70.1060 · Cited by 286
Antibacterial discovery and development—the failure of success?
Fernandes, P. (2006) · Nature Biotechnology · doi:10.1038/nbt1206-1497 · Cited by 246
Empirical antibacterial drug discovery—Foundation in natural products
Singh, S. B., & Barrett, J. F. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.12.016 · Cited by 245
Natural products as a screening resource
Harvey, A. L. (2007) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2007.08.012 · Cited by 223
Novel approaches to developing new antibiotics for bacterial infections
Coates, A. R. M., & Hu, Y. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707432 · Cited by 218
GlpD and PlsB Participate in Persister Cell Formation in Escherichia coli
Spoering, A. L., Vulić, M., & Lewis, K. (2006) · Journal of Bacteriology · doi:10.1128/jb.00369-06 · Cited by 214
Achievements and new knowledge unraveled by metagenomic approaches
Simon, C., & Daniel, R. (2009) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-009-2233-z · Cited by 208
Chiang, Y.-M., Szewczyk, E., Nayak, T., Davidson, A. D., Sanchez, J. F., Lo, H.-C., Ho, W.-Y., Simityan, H., Kuo, E., Praseuth, A., et al. (2008) · Chemistry & Biology · doi:10.1016/j.chembiol.2008.05.010 · Cited by 204
Křen, V., & Řezanka, T. (2008) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2008.00124.x · Cited by 187
Antibiotic effectiveness: Balancing conservation against innovation
Laxminarayan, R. (2014) · Science · doi:10.1126/science.1254163 · Cited by 170
Lin, X., Hopson, R., & Cane, D. E. (2006) · Journal of the American Chemical Society · doi:10.1021/ja061292s · Cited by 156
Gross, H. (2007) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-007-0900-5 · Cited by 151
Olle, B. (2013) · Nature Biotechnology · doi:10.1038/nbt.2548 · Cited by 147
Antibiotic-producing ability by representatives of a newly discovered lineage of actinomycetes
Busti, E., Monciardini, P., Cavaletti, L., Bamonte, R., Lazzarini, A., Sosio, M., & Donadio, S. (2006) · Microbiology · doi:10.1099/mic.0.28335-0 · Cited by 129
DAVIES, J. E. (2007) · EMBO Reports · doi:10.1038/sj.embor.7401022 · Cited by 128
Antibacterial drug discovery in the 21st century
Bush, K. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1465-0691.2004.1005.x · Cited by 106
Novel Antibiotics Targeting Respiratory ATP Synthesis in Gram-Positive Pathogenic Bacteria
Balemans, W., Vranckx, L., Lounis, N., Pop, O. I., Guillemont, J., Vergauwen, K., Mol, S., Gilissen, R., Motte, M., Lançois, D., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00273-12 · Cited by 96
The antibiotic R&D pipeline: an update
Jabes, D. L. (2011) · Current Opinion in Microbiology · doi:10.1016/j.mib.2011.08.002 · Cited by 96
Bacterial Hosts for Natural Product Production
Zhang, H., Wang, Y., & Pfeifer, B. A. (2008) · Molecular Pharmaceutics · doi:10.1021/mp7001329 · Cited by 91
Realism in drug discovery—could Cassandra be right?
Horrobin, D. F. (2001) · Nature Biotechnology · doi:10.1038/nbt1201-1099 · Cited by 79
UN High-Level Meeting on antimicrobials—what do we need?
Laxminarayan, R., Amábile-Cuevas, C. F., Cars, O., Evans, T., Heymann, D. L., Hoffman, S. J., Holmes, A. H., Mendelson, M., Sridhar, D., Woolhouse, M. E. J., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31079-0 · Cited by 78
Hugenholtz, P., Hooper, S. D., & Kyrpides, N. C. (2009) · Environmental Microbiology · doi:10.1111/j.1462-2920.2009.01949.x · Cited by 69
Drugs from hidden bugs: their discovery via untapped resources
Lefevre, F., Robe, P., Jarrin, C., Ginolhac, A., Zago, C., Auriol, D., Vogel, T. M., Simonet, P., & Nalin, R. (2008) · Research in Microbiology · doi:10.1016/j.resmic.2007.12.011 · Cited by 59
When will the genomics investment pay off for antibacterial discovery?
Mills, S. D. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.11.025 · Cited by 58
Can biotech deliver new antibiotics?
Barrett, J. F. (2005) · Current Opinion in Microbiology · doi:10.1016/j.mib.2005.08.007 · Cited by 52
Low hanging fruit in infectious disease drug development
Kraus, C. N. (2008) · Current Opinion in Microbiology · doi:10.1016/j.mib.2008.09.009 · Cited by 36
Mother nature's combinatorial libraries; their influence on the synthesis of drugs.
Kingston, D. G. I., & Newman, D. J. (2002) · PubMed · Cited by 34
Identification of genes for mycothiol biosynthesis in Streptomyces coelicolor A3(2).
Park, J., Cha, C., & Roe, J. (2006) · PubMed · Cited by 31
Investigational new treatments for Clostridium difficile infection
Ivarsson, M. E., Leroux, J., & Castagner, B. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.12.003 · Cited by 26
Bald, D., & Koul, A. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.09.007 · Cited by 20
Cited by
Recent Strategies to Develop Innovative Photosensitizers for Enhanced Photodynamic Therapy
Pham, T. C., Nguyen, V.-N., Choi, Y., Lee, S., & Yoon, J. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00381 · Cited by 1,813
Antimicrobial resistance: Impacts, challenges, and future prospects
Ahmed, S. K., Hussein, S., Qurbani, K., Ibrahim, R. H., Fareeq, A., Mahmood, K. A., & Mohamed, M. G. (2024) · Journal of Medicine, Surgery, and Public Health · doi:10.1016/j.glmedi.2024.100081 · Cited by 1,213
Rejuvenated Photodynamic Therapy for Bacterial Infections
Jia, Q., Song, Q., Li, P., & Huang, W. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201900608 · Cited by 426
Reassessing the Host Defense Peptide Landscape
Haney, E. F., Straus, S. K., & Hancock, R. E. W. (2019) · Frontiers in Chemistry · doi:10.3389/fchem.2019.00043 · Cited by 359
Antibiotic Discovery: Where Have We Come from, Where Do We Go?
Ribeiro da Cunha, B., Fonseca, L. P., & Calado, C. R. C. (2019) · Antibiotics · doi:10.3390/antibiotics8020045 · Cited by 353
Metadata
- Authors
- Martens, E., & Demain, A. L.
- Venue
- The Journal of Antibiotics
- Published
- 2017-03-01
- Volume
- 70
- Issue
- 5
- Pages
- 520-526
- ISSN
- 0021-8820 (ISSN-L)
- 1881-1469
- OpenAlex
- W2593634873
- Cited by
- 445
- References
- 57
- FWCI
- 15.44
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.